Abbott advances coronary artery disease treatment with new intravascular lithotripsy trial
Abbott’s Coronary Intravascular Lithotripsy (IVL) System gets FDA approval for a clinical trial to enhance coronary artery disease treatment—learn more. Read More
STIMIT AG begins trial for noninvasive diaphragm stimulation device
STIMIT AG, a medical technology innovator, has launched patient enrollment for its pivotal clinical trial assessing a noninvasive diaphragm neurostimulation device. This device, the STIMIT ... Read More